Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of authorisation: 17/09/2017, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of authorisation: 17/09/2017, Revision: 16, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva Gm+REOm, avian infectious bursal disease,avian reovirus vaccine (inactivated), Status: Opinion

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva Gm+REOm, avian infectious bursal disease,avian reovirus vaccine (inactivated), Status: Opinion

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND, avian infectious bronchitis virus,Newcastle disease virus vaccine (inactivated), Status: Opinion

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND, avian infectious bronchitis virus,Newcastle disease virus vaccine (inactivated), Status: Opinion

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness